Survey of ophthalmology最新文献

{"title":"New developments in the management of persistent corneal epithelial defects","authors":"María García-Lorente MD, Marina Rodríguez-Calvo-de-Mora MD PhD, José-María Sánchez-González OD PhD, Davide Borroni MD PhD, Francisco Zamorano-Martín MD, Carlos Rocha-de-Lossada MD PhD","doi":"10.1016/j.survophthal.2023.07.005","DOIUrl":"10.1016/j.survophthal.2023.07.005","url":null,"abstract":"","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10082046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Surgical and anesthetic influences of the oculocardiac reflex in adults and children during strabismus surgery","authors":"Robert W. Arnold MD","doi":"10.1016/j.survophthal.2023.06.005","DOIUrl":"10.1016/j.survophthal.2023.06.005","url":null,"abstract":"","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9637123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ocular surface toxicities associated with modern anticancer therapies","authors":"Rafael Boucher MD ,&nbsp;Oscar Haigh PhD ,&nbsp;Emmanuel Barreau MD ,&nbsp;Stéphane Champiat MD, PhD ,&nbsp;Olivier Lambotte MD, PhD ,&nbsp;Clovis Adam MD ,&nbsp;Marc Labetoulle MD, PhD ,&nbsp;Antoine Rousseau MD, PhD","doi":"10.1016/j.survophthal.2023.10.002","DOIUrl":"10.1016/j.survophthal.2023.10.002","url":null,"abstract":"<div><p><span><span><span><span>Cancer treatments have recently shifted from broad-spectrum </span>cytotoxic therapies to more focused treatments, maximizing anticancerous activity while reducing toxicity to healthy cells. These modern </span>anticancer therapies (MATs) encompass a wide range of innovative molecules that include </span>immune checkpoint inhibitors<span><span> and other targeted anticancer therapies, comprising antibody drug conjugates<span> and inhibitors of signal transduction. Some MATs are associated with </span></span>ocular surface<span> adverse events that can cause severe discomfort and even lead to loss of vision. While these complications remain rare, they are probably underreported. It is likely that both oncologists and ophthalmologists will come across MATs-associated ocular surface-adverse events in their practices, owing to the increasing number of patients being treated with MATs. Rapid identification of ocular surface-adverse events is crucial, as early intervention can manage these conditions to avoid vision loss and reduce negative impacts on </span></span></span>quality of life. We discuss characteristics of ocular surface pathologies attributed to MATs, describe the suspected underlying pathophysiological mechanisms, and outline the main lines of treatment.</p></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41170960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Corrigendum to “Future directions in managing aniridia-associated keratopathy” [Surv Ophthalmol 68 (2023) 940–956]","authors":"Arianne J.H. van Velthoven ,&nbsp;Tor P. Utheim ,&nbsp;Maria Notara ,&nbsp;Dominique Bremond-Gignac ,&nbsp;Francisco C. Figueiredo ,&nbsp;Heli Skottman ,&nbsp;Daniel Aberdam ,&nbsp;Julie T. Daniels ,&nbsp;Giulio Ferrari ,&nbsp;Christina Grupcheva ,&nbsp;Carina Koppen ,&nbsp;Mohit Parekh ,&nbsp;Thomas Ritter ,&nbsp;Vito Romano ,&nbsp;Stefano Ferrari ,&nbsp;Claus Cursiefen ,&nbsp;Neil Lagali ,&nbsp;Vanessa L.S. LaPointe ,&nbsp;Mor M. Dickman","doi":"10.1016/j.survophthal.2024.01.001","DOIUrl":"10.1016/j.survophthal.2024.01.001","url":null,"abstract":"","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0039625724000018/pdfft?md5=1c04d4b05dca777dfc4d55d9d0706795&pid=1-s2.0-S0039625724000018-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139703466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Observations on the association between obstructive sleep apnea and floppy eyelid syndrome: A systematic review and meta-analysis","authors":"Jian S. Chan BMedStud,&nbsp;Matthew K. Lee MD,&nbsp;Peter J. Tweedie BVisSci,&nbsp;Claudia J. Tiong BVisSci,&nbsp;Amy T. Tsoi BMedStud,&nbsp;Aadhavi Vasanthan BMedStud,&nbsp;Jed Maegraith BSc (MedSci),&nbsp;Grace A. Borchert MD,&nbsp;James R. Gunasegaram BMedSci,&nbsp;Anna M. Waldie MD,&nbsp;Geoff Wilcsek FRANZCO,&nbsp;Ian C. Francis FRACS, FRANZCO, PhD","doi":"10.1016/j.survophthal.2023.10.001","DOIUrl":"10.1016/j.survophthal.2023.10.001","url":null,"abstract":"","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41183635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cataractogenesis and molecular pathways, with reactive free oxygen species as a common pathway","authors":"Arturo Iván Pérez Pacheco","doi":"10.1016/j.survophthal.2023.11.001","DOIUrl":"10.1016/j.survophthal.2023.11.001","url":null,"abstract":"<div><p>Slowing down or stopping the natural process of cataractogenesis<span> is certainly a challenge for those who today propose an option other than surgery. Addressing the same problem in different ways constitutes a new approach to solving what is today the number one cause of reversible blindness worldwide. The technological revolution, as well as the advances in the biological sciences, allows us to conceive mechanisms never thought of before to stop the process that, as a common pathway, constitutes opacification of the crystalline lens. A new dawn for cataracts is coming through molecular, newly-discovered mechanisms. Cataractogenesis and molecular pathways have reactive free oxygen species as a common pathway. Surgical removal is today's gold standard, but perhaps not for much longer.</span></p></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72015491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Not just any headache","authors":"Janet Fan BA ,&nbsp;Pamela Davila MD ,&nbsp;Noor Laylani MD ,&nbsp;Andrew G. Lee MD ,&nbsp;Benjamin Frishberg MD, FAAN","doi":"10.1016/j.survophthal.2023.10.009","DOIUrl":"10.1016/j.survophthal.2023.10.009","url":null,"abstract":"<div><p><span><span>A 40-year-old man with a history of traumatic retinal detachment in the left eye treated with </span>scleral buckle<span> and migraine with aura presented to clinic for persistent blurry vision of the right eye following an episode of migraine with aura. The patient had experienced migraines with visual auras starting as a teenager, which normally resolve within an hour except for the most recent episode. Humphrey visual field showed a right superior homonymous </span></span>quadrantanopia<span><span><span>. Computed tomography of the head<span> without contrast showed acute ischemia in the left </span></span>occipital lobe<span>. Magnetic resonance imaging of the brain confirmed an ischemic infarct of the left occipital lobe. There were no significant abnormalities in complete blood count, metabolic panel, coagulation studies, and infectious testing. Echocardiogram<span><span> and transthoracic echocardiography were normal as well, but further work up by </span>cardiology revealed a </span></span></span>patent foramen ovale<span> on transesophageal echocardiogram<span>. This case illustrates a rare case of migrainous infarction, which should be considered as a possible complication of migraine with aura, presenting with persistent visual changes.</span></span></span></p></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136127490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Uveal melanoma in African Americans: Diagnostic challenges","authors":"Yağmur Seda Yeşiltaş MD ,&nbsp;Zackery Oakey MD ,&nbsp;Jacquelyn Wrenn NP ,&nbsp;Gabrielle Yeaney MD ,&nbsp;Jennifer Brainard MD ,&nbsp;Brandy Lorek BSN ,&nbsp;Arun D. Singh MD","doi":"10.1016/j.survophthal.2023.06.011","DOIUrl":"10.1016/j.survophthal.2023.06.011","url":null,"abstract":"<div><p>Uveal melanoma (UM) is uncommon in African Americans. Owing to its rarity, UM may not be suspected in African Americans leading to delayed diagnosis. In addition, socioeconomic factors may also play a role in delayed diagnosis. Clinical and ultrasonographic features may be atypical due to racial pigmentation, necessitating diagnostic fine needle aspiration biopsy. Herein, we report an illustrative case series of 12 African Americans with UM highlighting clinical features and diagnostic challenges.</p></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10114387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Systematic review of prognostic factors associated with progression to late age-related macular degeneration: Pinnacle study report 2","authors":"Ahmed M. Hagag ,&nbsp;Rebecca Kaye ,&nbsp;Vy Hoang ,&nbsp;Sophie Riedl ,&nbsp;Philipp Anders ,&nbsp;Beth Stuart ,&nbsp;Ghislaine Traber ,&nbsp;Christian Appenzeller-Herzog ,&nbsp;Ursula Schmidt-Erfurth ,&nbsp;Hrvoje Bogunovic ,&nbsp;Hendrik P. Scholl ,&nbsp;Toby Prevost ,&nbsp;Lars Fritsche ,&nbsp;Daniel Rueckert ,&nbsp;Sobha Sivaprasad ,&nbsp;Andrew J. Lotery","doi":"10.1016/j.survophthal.2023.10.010","DOIUrl":"10.1016/j.survophthal.2023.10.010","url":null,"abstract":"<div><p>There is a need to identify accurately prognostic factors that determine the progression of intermediate to late-stage age-related macular degeneration (AMD). Currently, clinicians cannot provide individualised prognoses of disease progression. Moreover, enriching clinical trials with rapid progressors may facilitate delivery of shorter intervention trials aimed at delaying or preventing progression to late AMD. Thus, we performed a systematic review to outline and assess the accuracy of reporting prognostic factors for the progression of intermediate to late AMD. A meta-analysis was originally planned. Synonyms of AMD and disease progression were used to search Medline and EMBASE for articles investigating AMD progression published between 1991 and 2021. Initial search results included 3229 articles. Predetermined eligibility criteria were employed to systematically screen papers by two reviewers working independently and in duplicate. Quality appraisal and data extraction were performed by a team of reviewers. Only 6 studies met the eligibility criteria. Based on these articles, exploratory prognostic factors for progression of intermediate to late AMD included phenotypic features (e.g. location and size of drusen), age, smoking status, ocular and systemic co-morbidities, race, and genotype. Overall, study heterogeneity precluded reporting by forest plots and meta-analysis. The most commonly reported prognostic factors were baseline drusen volume/size, which was associated with progression to neovascular AMD, and outer retinal thinning linked to progression to geographic atrophy. In conclusion, poor methodological quality of included studies warrants cautious interpretation of our findings. Rigorous studies are warranted to provide robust evidence in the future.</p></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0039625723001406/pdfft?md5=f6da2dfb08f63f06e4b594d7020b33e8&pid=1-s2.0-S0039625723001406-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"61565381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Management of vernal keratoconjunctivitis: Navigating a changing treatment landscape","authors":"Asim Ali MD ,&nbsp;Leonard Bielory MD ,&nbsp;Stephanie Dotchin MD, FRCSC ,&nbsp;Patrick Hamel MD, FRCSC ,&nbsp;Yi Ning J. Strube MD, MS, FRCSC ,&nbsp;Euna B. Koo MD","doi":"10.1016/j.survophthal.2023.10.008","DOIUrl":"10.1016/j.survophthal.2023.10.008","url":null,"abstract":"<div><p>Vernal keratoconjunctivitis (VKC) is a chronic, progressive, and potentially sight-threatening form of ocular inflammatory disease that primarily affects children and young adults. Prevalence varies by region, ranging from &lt;2 per 10,000 in the United States to as high as 1,100 per 10,000 in parts of Africa. The rarity of VKC in developed countries can make differential diagnosis challenging, and treatment is often delayed until the disease is advanced, and symptoms are significantly impacting patients’ quality of life. Although once viewed primarily as an immunoglobulin E-mediated condition, approximately 50% of patients with VKC do not exhibit allergic sensitization. It is now recognized that the immunopathology of VKC involves multiple inflammatory pathways that lead to the signs, symptoms, and conjunctival eosinophilic and fibroproliferative lesions that are a hallmark of the disease. We examine the evolution of our understanding of the immunopathology of VKC, the expanding VKC treatment armamentarium, the clinical implications of emerging treatment approaches, and future directions for VKC research and practice.</p></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0039625723001388/pdfft?md5=bca924b1f2b035afe2c5dfb1a2a7b981&pid=1-s2.0-S0039625723001388-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"61565380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}